HomeHealthcare & Life Sciences Ambulatory Infusion Centers Market

Global Ambulatory Infusion Centers Market Size, Share & Trends Analysis Report By Therapy Type (Anti-infective Therapy, Hydration Therapy, Chemotherapy, Immunoglobulin Therapy), By Application (Oncology, Autoimmune DisordersRheumatoid ArthritisMultiple SclerosisCrohnâs DiseasePsoriasis, Neurological Disorders, Infectious Diseases), By Country (North America, Europe, APAC, Middle East and Africa, Latin America) and Forecast, 2026-2034

Starting From
USD 3950

Buy Now

Report Benefits

Develop business strategies by understanding the trends shaping and driving the Market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track sales in the global and country-specific Market.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Ambulatory Infusion Centers Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Ambulatory Infusion Centers Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Ambulatory Infusion Centers Market, By Therapy Type
1. Introduction
  1. Market Size and Forecast, By Therapy Type
2. Anti-infective Therapy
  1. Market Size and Forecast, By Region
3. Hydration Therapy
  1. Market Size and Forecast, By Region
4. Chemotherapy
  1. Market Size and Forecast, By Region
5. Immunoglobulin Therapy
  1. Market Size and Forecast, By Region
6. Biological Therapy
  1. Market Size and Forecast, By Region
7. Enteral and Parenteral Nutrition
  1. Market Size and Forecast, By Region
8. Others (e.g., corticosteroids, pain management infusions)
  1. Market Size and Forecast, By Region
Ambulatory Infusion Centers Market, By Application
1. Introduction
  1. Market Size and Forecast, By Application
2. Oncology
  1. Market Size and Forecast, By Region
3. Autoimmune Disorders
  1. Market Size and Forecast, By Region
  2. Rheumatoid Arthritis
    1. Market Size and Forecast, By Region
  3. Multiple Sclerosis
    1. Market Size and Forecast, By Region
  4. Crohn’s Disease
    1. Market Size and Forecast, By Region
  5. Psoriasis
    1. Market Size and Forecast, By Region
4. Neurological Disorders
  1. Market Size and Forecast, By Region
5. Infectious Diseases
  1. Market Size and Forecast, By Region
6. Gastrointestinal Disorders
  1. Market Size and Forecast, By Region
7. Immune Deficiencies
  1. Market Size and Forecast, By Region
8. Others
  1. Market Size and Forecast, By Region
Ambulatory Infusion Centers Market, By End-User
1. Introduction
  1. Market Size and Forecast, By End-User
2. Hospital-Affiliated Infusion Centers
  1. Market Size and Forecast, By Region
3. Physician Office Infusion Centers (POICs)
  1. Market Size and Forecast, By Region
4. Standalone/Independent Infusion Centers
  1. Market Size and Forecast, By Region
5. Home Infusion Service Providers (with ambulatory setups)
  1. Market Size and Forecast, By Region
Ambulatory Infusion Centers Market, By Payor Type
1. Introduction
  1. Market Size and Forecast, By Payor Type
2. Commercial Insurance
  1. Market Size and Forecast, By Region
3. Medicare
  1. Market Size and Forecast, By Region
4. Medicaid
  1. Market Size and Forecast, By Region
5. Out-of-Pocket / Self-Pay
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  2. U.S.
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  2. U.K.
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  2. China
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  3. South Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  2. UAE
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  2. Brazil
    1. By Therapy Type
      1. Anti-infective Therapy
      2. Hydration Therapy
      3. Chemotherapy
      4. Immunoglobulin Therapy
      5. Biological Therapy
      6. Enteral and Parenteral Nutrition
      7. Others (e.g., corticosteroids, pain management infusions)
    2. By Application
      1. Oncology
      2. Autoimmune Disorders
      3. Neurological Disorders
      4. Infectious Diseases
      5. Gastrointestinal Disorders
      6. Immune Deficiencies
      7. Others
    3. By End-User
      1. Hospital-Affiliated Infusion Centers
      2. Physician Office Infusion Centers (POICs)
      3. Standalone/Independent Infusion Centers
      4. Home Infusion Service Providers (with ambulatory setups)
    4. By Payor Type
      1. Commercial Insurance
      2. Medicare
      3. Medicaid
      4. Out-of-Pocket / Self-Pay
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2025
1. Introduction
2. Ambulatory Infusion Centers Market Share Analysis, 2025 (%)
  1. Market Share Analysis, 2025
  2. Competition Ranking, 2025
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Option Care Health
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. CVS Health / Coram
3. UnitedHealth Group / Optum
4. Cencora
5. BrightSpring Health Services
6. Vivo Infusion
7. IVX Health
8. TwelveStone Health Partners
9. Palmetto Infusion
10. Metro Infusion Center
11. Infusion for Health
12. Pure Infusion Suites
13. AIS Healthcare
14. Amerita
15. Soleo Health

Report Benefits

Table of Contents